Viatris is a global healthcare company that develops, manufactures, and markets a diverse portfolio of prescription products, including generic and branded medicines, vaccines, and over-the-counter (OTC) products. The company's product lineup includes a range of therapeutic areas, including cardiovascular, infectious diseases, and oncology, among others. As a leading player in the generic and biosimilar markets, Viatris plays a critical role in increasing access to affordable medicines globally.
S&P 500 closing prices, top movers, and sector performance — delivered daily.